current study reviewed the literature related to the effects of conversion from ticagrelor to clopidogrel in ACS patients after PCI to provide references for the drug’s rational clinical ... evaluating specific points…
coronary artery disease (CAD) in DM is yet unknown. Although acetylsalicylic acid and clopidogrel are prescribed individually or in combination for high-cardiovascular risk patients with overall improvements in outcomes…
Clopidogrel resistance plays a key role in ischemic recurrence after Percutaneous coronary intervention (PCI). The cytochrome P450 (CYP)–dependent conversion of Clopidogrel to its active metabolite may contribute…
Clopidogrel resistance plays a key role in ischemic recurrence after Percutaneous coronary intervention (PCI). The cytochrome P450 (CYP)–dependent conversion of Clopidogrel to its active metabolite may contribute…
Clopidogrel hydrogen sulfate (CHS) is a thienopyridine, which can be used to prevent cardiovascular complications alone or in combination with acetyl salicylic acid as an important antiplatelet agent. Clopidogrel…
study was to provide the analysis of genetic and non-genetic factors that influence clopidogrel efficacy in cardiology patients. Methods: We have conducted a prospective study in 200 hospitalized patients ... PREDICT…
Background: Clopidogrel is considered one of the most important drugs used either alone or in combination with aspirin to reduce the risk of major cardiovascular conditions including heart diseases ... patients who…
Purpose: To describe how VerifyNow P2Y12 testing for clopidogrel response is being utilized at a community hospital. Methods: A retrospective chart review was conducted at a 411-bed community hospital ... patients who…
studies have suggested that proton pump inhibitors (PPIs) may inhibit the antiplatelet activity of clopidogrel, increasing the risk of major cardiovascular events in patients taking clopidogrel and PPIs together. AimThe…
admitted in the emergency room are treated with AAS and a loading dose of clopidogrel (300-600 mg) unless contraindicated. A 47 year old male was admitted in the cardiology ... revascularized with two drug eluting…
Statement of the Problem: Vicagrel is a novel analog of Clopidogrel, which was expected to be hydrolyzed into its active metabolites via esterase instead of CYP2C19. In addition, both, Vicagrel ... Clopidogrel have same…
observed that statins (some), proton pump inhibitors and other drugs interfere significantly with clopidogrel metabolism. In this study, patients (n=213) hospitalized for major cardiovascular problems (stable angina, ST…
patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) on clopidogrel therapy in Zhengzhou city for guidance on clinical medication and reduction in the incidence of…
Acute Coronary Syndromes (ACS) patients. However, an inter-individual variability in platelet response to Clopidogrel has been found in a substantial group of them. Genetic is known be the dominant ... individual and…
Background: Clopidogrel is an antiplatelet agent used in the treatment of vascular diseases. It requires in vivo bio activation linked to the cytochrome P450. Several studies reported that paraoxonase ... PON1) was a…
novel stability-indicating ultra fast LC method for separation and estimation of impurities in clopidogrel and aspirin in their combined tablet dosage form and omeprazole was developed and validated according…
percutaneous coronary intervention. We studied the long term efficacy of prasugrel compared with clopidogrel loading in patients undergoing percutaneous coronary intervention (PCI), electively or emergently, who were…
aimed to evaluate the bioequivalence of clopidogrel in healthy Chinese volunteers after administration of a single oral dose. We administered a single oral dose of 75 mg clopidogrel (test ... healthy Chinese volunteers…
used to prevent problems with blood clots such as heart attacks or strokes. Clopidogrel is a pro-drug, which needs to be activated through the action of cytochrome P450 ... prevent upper gastrointestinal bleeding…
This study aims to assess the quality parameters of Clopidogrel tablets from different manufacturers available in the Bangladeshi market. Clopidogrel is a potent antiplatelet and antithrombotic drug. Clopidogrel has…
inhibitors is one of the risk factors associated with treatment failure or unresponsiveness for clopidogrel therapy. Our objective is to describe the prescribing patterns of proton pump inhibitors among ... Methodology…
Background: Antiplatelet therapy with clopidogrel is generally used to decrease the risk of ischemic heart disease. Environmental and genetic factors including SNPs in CYP3A5 and P2RY12 genes are attributed ... study is…
Introduction: Clopidogrel improves intravascular stent patency reduces ischemic events but there are little data on its effect fallowing OPCAB. This study was designed to Material and Method: In this randomized…
Background: Antiplatelet therapy with clopidogrel is generally used to decrease the risk of ischemic heart disease. Environmental and genetic factors including SNPs in CYP3A5 and P2RY12 genes are attributed ... drug…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.